title: Inflammation in age-related macular degeneration.
abstract: Age-related macular degeneration (AMD) is the leading cause of legal blindness in elderly individuals in the developed world, affecting 30-50 million people worldwide. AMD primarily affects the macular region of the retina that is responsible for the majority of central, color and daytime vision. The presence of drusen, extracellular protein aggregates that accumulate under the retinal pigment epithelium (RPE), is a major pathological hallmark in the early stages of the disease. The end stage 'dry' and 'wet' forms of the disease culminate in vision loss and are characterized by focal degeneration of the RPE and cone photoreceptors, and choroidal neovascularization (CNV), respectively. Being a multifactorial and genetically heterogeneous disease, the pathophysiology of AMD remains unclear, yet, there is ample evidence supporting immunological and inflammatory processes. Here, we review the recent literature implicating some of these immune processes in human AMD and in animal models.
authors.affiliation: Ocular Genetics Unit, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland, ozakie@tcd.ie.
authors.forename: Ema
authors.initials: E
authors.lastname: Ozaki
authors.forename: Matthew
authors.initials: M
authors.lastname: Campbell
authors.forename: Anna-Sophia
authors.initials: AS
authors.lastname: Kiang
authors.forename: Marian
authors.initials: M
authors.lastname: Humphries
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Doyle
authors.forename: Peter
authors.initials: P
authors.lastname: Humphries
mesh_terms: D006801:Humans; D007249:Inflammation / Q000276:immunology*; D008268:Macular Degeneration / Q000276:immunology*; D015594:Optic Disk Drusen / Q000276:immunology*; D012173:Retinitis / Q000276:immunology*; D015398:Signal Transduction / Q000276:immunology*